Immuron Q3 FY23 Business Update Presentation

April 19, 2023

https://www.globenewswire.com/news-release/2023/04/19/2649787/37134/en/Immuron-Q3-FY23-Business-Update-Presentation.html

MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) — Immuron Limited (ASX:IMC; NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to provide the Q3 FY23 Investor Presentation for the business update webinar to be held today at 11:00 am (AEST).

Read more at globenewswire.com

Related news for (IMRN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.